205 related articles for article (PubMed ID: 1299992)
1. [Lyell syndrome or toxic epidermal necrolysis and Stevens-Johnson syndrome after treatment with fluoxetine].
Bodokh I; Lacour JP; Rosenthal E; Chichmanian RM; Perrin C; Vitetta A; Ortonne JP
Therapie; 1992; 47(5):441. PubMed ID: 1299992
[No Abstract] [Full Text] [Related]
2. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
3. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
Aberer W; Stingl G; Wolff K
Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
[TBL] [Abstract][Full Text] [Related]
4. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
Jezierska-Krupa B; Hyla-Klekot L
Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
[TBL] [Abstract][Full Text] [Related]
5. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
Porteous DM; Berger TG
Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
[No Abstract] [Full Text] [Related]
6. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lee HY; Pang SM; Thamotharampillai T
J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
[No Abstract] [Full Text] [Related]
8. Erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients.
Castaneda CP; Brandenburg NA; Bwire R; Burton GH; Zeldis JB
J Clin Oncol; 2009 Jan; 27(1):156-7. PubMed ID: 19047275
[No Abstract] [Full Text] [Related]
9. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
Rijal A; Agrawal S
Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
[No Abstract] [Full Text] [Related]
10. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
Wolkenstein P
Therapie; 1996; 51(5):500-1. PubMed ID: 9138383
[No Abstract] [Full Text] [Related]
11. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
[TBL] [Abstract][Full Text] [Related]
12. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
Watanabe H
Nihon Rinsho; 2012 Aug; 70 Suppl 6():492-7. PubMed ID: 23156557
[No Abstract] [Full Text] [Related]
13. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
14. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC
J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188
[No Abstract] [Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy.
Valeyrie-Allanore L; Poulalhon N; Fagot JP; Sekula P; Davidovici B; Sidoroff A; Mockenhaupt M
Radiother Oncol; 2008 May; 87(2):300-3. PubMed ID: 18328585
[TBL] [Abstract][Full Text] [Related]
16. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
17. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
van der Meer JB
Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
[No Abstract] [Full Text] [Related]
18. [Case-control surveillance of Stevens-Johnson syndrome and Lyell's syndrome. Presentation of the GISED project].
G Ital Dermatol Venereol; 1989 Oct; 124(10):435-40. PubMed ID: 2635688
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
Dainichi T; Uchi H; Moroi Y; Furue M
Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
[No Abstract] [Full Text] [Related]
20. Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.
Wäsch R; Jakob T; Technau K; Finke J; Engelhardt M
Ann Hematol; 2012 Feb; 91(2):287-9. PubMed ID: 21494796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
